Loading...
Paramount Bed Holdings Co., Ltd.
PBHDF•PNK
Healthcare
Medical - Instruments & Supplies
$19.74
$0.00(0.00%)
Paramount Bed Holdings Co., Ltd. (PBHDF) Financial Performance & Income Statement Overview
Review Paramount Bed Holdings Co., Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
2.42%
↑ 2.42%
Operating Income Growth
-6.09%
↓ 6.09%
Net Income Growth
-14.48%
↓ 14.48%
Operating Cash Flow Growth
38.94%
↑ 38.94%
Operating Margin
11.59%
↑ 11.59%
Gross Margin
47.95%
↑ 47.95%
Net Profit Margin
9.18%
↑ 9.18%
ROE
7.27%
↑ 7.27%
ROIC
7.96%
↑ 7.96%
Paramount Bed Holdings Co., Ltd. (PBHDF) Income Statement & Financial Overview
Review Paramount Bed Holdings Co., Ltd.'s (PBHDF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $33.51B | $26.39B | $25.53B | $23.14B |
| Cost of Revenue | $17.33B | $13.58B | $13.23B | $11.89B |
| Gross Profit | $16.18B | $12.82B | $12.30B | $11.26B |
| Gross Profit Ratio | $0.48 | $0.49 | $0.48 | $0.49 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $10.42B | $9.72B | $9.85B | $9.70B |
| Operating Expenses | $10.42B | $9.70B | $9.85B | $9.66B |
| Total Costs & Expenses | $27.75B | $23.28B | $23.08B | $21.55B |
| Interest Income | $99.00M | $106.00M | $93.00M | $127.00M |
| Interest Expense | $45.00M | -$81.00M | $40.00M | $37.00M |
| Depreciation & Amortization | $2.90B | $2.44B | $2.79B | $2.44B |
| EBITDA | $8.48B | $5.53B | $3.70B | $4.003B |
| EBITDA Ratio | $0.25 | $0.21 | $0.14 | $0.17 |
| Operating Income | $5.76B | $3.12B | $2.45B | $1.59B |
| Operating Income Ratio | $0.17 | $0.12 | $0.10 | $0.07 |
| Other Income/Expenses (Net) | -$761.00M | $1.67B | -$1.58B | $588.00M |
| Income Before Tax | $5.002B | $4.78B | $869.00M | $2.18B |
| Income Before Tax Ratio | $0.15 | $0.18 | $0.03 | $0.09 |
| Income Tax Expense | $1.79B | $1.18B | $162.00M | $615.00M |
| Net Income | $3.21B | $3.60B | $706.00M | $1.57B |
| Net Income Ratio | $0.10 | $0.14 | $0.03 | $0.07 |
| EPS | $57.19 | $63.01 | $12.27 | $27.27 |
| Diluted EPS | $57.19 | $63.01 | $12.27 | $27.27 |
| Weighted Avg Shares Outstanding | $56.18M | $57.10M | $57.52M | $57.42M |
| Weighted Avg Shares Outstanding (Diluted) | $56.07M | $57.10M | $57.52M | $57.42M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan